Exploration of small molecules as inhibitors of potential BACE1 protein to treat amyloid cerebrovascular disease by employing molecular modeling and simulation approaches
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0317716 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Zhizhong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Amyloid Precursor Protein Secretases, Aspartic Acid Endopeptidases, Small Molecule Libraries, Cerebrovascular Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Natural Science Foundation Program.
Abstract (Originalsprache)
Amyloid cerebrovascular disease, primarily driven by the accumulation of amyloid-beta (Aβ) peptides, is intricately linked to neurodegenerative disorders like Alzheimer’s disease. BACE1 (beta-site amyloid precursor protein cleaving enzyme 1) plays a critical role in the production of Aβ, making it a key therapeutic target. In the current work, a CNS library of ChemDiv database containing 44085 compounds was screened against the BACE1 protein. Initially, a structure-based pharmacophore hypothesis was constructed, followed by virtual screening, with the screened hits docked to the BACE1 protein to determine the optimal binding modes. The docking results were examined using the glide gscore and chemical interactions of the docked molecules. The cutoff value of −5 kcal/mol was used to select hits with high binding affinities. A total of seven hits were chosen based on the glide g score. Furthermore, the possible binding mechanisms of the docked ligands were investigated, and it was discovered that all seven selected ligands occupied the same site in the predicted binding pocket of protein. The bioactivity scores of the compounds demonstrated that the chosen compounds possess the features of lead compounds. The toxicity risks and ADMET features of the selected hits were anticipated, and four compounds, J032-0080 , SC13-0774 , V030-0915 , and V006-5608 were chosen for stability analysis. The selected hits were extremely stable and strongly bound to the BACE1 pocket, and conformational changes caused by RMSD, RMSF, and protein-ligand interactions were assessed using MD modeling. Similarly, principal component analysis revealed a large static number of hydrogen bonds. The MM/GBSA binding free energies maps revealed a significant energy contribution in the binding of selected hits to BACE1. The binding free energy landscapes indicated that the hits were bound with a high binding affinity. Thus, the hits could serve as lead compounds in biophysical investigations to limit the biological activity of the BACE1 protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- The Third People's Hospital of Hubei Province, Affiliated Jianghan University, Wuhan, Hubei, China.
ORCID-Profile: Zhizhong Wang
Förderung
- Hubei Natural Science Foundation Program
Zitieren
APA
Wang, Z., Li, Z., Lin, A., Zhang, Q., Chen, Y., Bie, B., & Feng, J. (2025). Exploration of small molecules as inhibitors of potential BACE1 protein to treat amyloid cerebrovascular disease by employing molecular modeling and simulation approaches. PLOS ONE. https://doi.org/10.1371/journal.pone.0317716
Vancouver
Wang Z, Li Z, Lin A, Zhang Q, Chen Y, Bie B, et al. Exploration of small molecules as inhibitors of potential BACE1 protein to treat amyloid cerebrovascular disease by employing molecular modeling and simulation approaches. PLOS ONE. 2025. doi:10.1371/journal.pone.0317716
BibTeX
@article{Wang2025,
author = {Wang, Zhizhong and Li, Zhiyong and Lin, Ailong and Zhang, Qing and Chen, Yingchun and Bie, Bizhou and Feng, Juanjuan},
title = {Exploration of small molecules as inhibitors of potential BACE1 protein to treat amyloid cerebrovascular disease by employing molecular modeling and simulation approaches},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0317716}
}
EUVIMED